← Open Payments lookup

SERGIO RODARTE-ROJAS: Open Payments

NPI 1518172105 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,109 in 52 payments from 10 companies in 2025. Trend: 2023 $635 · 2024 $676 · 2025 $1,109

Food & beverage: $998Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$239
E.R. Squibb & Sons, L.L.C.8$184
Lundbeck LLC8$177
Teva Pharmaceuticals USA, Inc.5$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Axsome Therapeutics, Inc.4$97
Alkermes, Inc.3$58
Otsuka America Pharmaceutical, Inc.3$55
Mallinckrodt Hospital Products Inc.1$33
ABBVIE INC.1$19

Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, Auvelity, ARISTADA, ACTHAR, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.